Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the domain of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and therapy are transforming the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering potential for more curative treatment options.